Anthropic: It’s “Critical” To Bring Company Products to EHR
The head of Anthropic's biology and life sciences business spoke about introducing "first-party" products, having a presence inside the EHR and what Claude can do for rural hospitals.
COO of Mayo Clinic Platform Believes De-identified Data Leads to Loss of Utility for Pharma, Other Third Parties
Mayo Clinic has about 100 petabytes of structured and unstructured EHR data, and about 28 petabytes have been de-identified, but in the Mayo Clinic way. Now that data capability is being combined with institutional expertise to provide a compelling case for pharma companies looking to leverage data, AI and provider expertise in drug development.
presented by
Esperion Sets Its Sights on New Areas While Maintaining Commitment to Cardiovascular Health
In a recent interview, Esperion president and CEO, Sheldon Koenig talks about the reality of statin intolerance and his company’s expansion into new diseases
Lilly’s Chief Information & Digital Officer: AI Use Goes Far Beyond Just Drug Discovery
Elli Lilly has been in the news lately because of the announced $1 billion investment in a joint innovation lab with Nvidia, an AI powerhouse player. But AI drug discovery is only part of the story of where AI can be leveraged in biopharma.
Butterfly Medical Offers Non-Surgical Option to Treat Enlarged Prostate
The CEO of the Israeli company believes the company has a superior, minimally invasive product that is designed to be a permanent implant, though the procedure is fully reversible.
DexCom’s CEO Believes Diabetics On GLP-1s Should Also Wear CGMs
Jake Leach became DexCom's chief executive on January 1 and is trying to write the turnaround story of this innovative medtech company. One story to tell is how CGMs should be a no-brainer for type 2 diabetes patients on GLP-1 weight loss drugs.
What if Oprah Knew About Fractyl Health?
People like Oprah Winfrey have struggled to maintain their weight loss after weaning themselves off GLP-1s. What if an outpatient medtech procedure did the trick?
presented by
RCM Outsourcing: Balancing Human Expertise & Smart Technology
Greenway Health blends smart technology with human expertise to elevate revenue cycle.
WaPo Columnist and CMS Official Provide Dueling Narratives of ChatGPT Health
The main question about health bots is accuracy and the trust or distrust that it engenders among users as a result. One journalist from the Washington Post and a strategic advisor to CMS had wildly differing experiences.
Nvidia CEO to Lilly CEO: You were running around the forest …
Jensen Huang, CEO of Nvidia and David Ricks, CEO of Eli Lilly, discussed their recently-announced partnership and the potential of GLP-1s at an event in San Francisco.
UPMC Enterprises’ Biopharma Lead: We are At a Tipping Point When it Comes to China
Matthias Kleinz, executive vice president and head of translational sciences investments at UPMC Enterprises, explained why biopharma companies cannot ignore China anymore.
What Merck’s Chief Medical Officer Thinks of Lilly’s Approach to GLP-1s
Eliav Barr gave kudos to Eli Lilly for testing the company's Zepbound weight loss drug in combination with a psoriatic arthritis drug to achieve better results for the underlying inflammation.
presented by
Enhanced Direct Enrollment: Georgia Access and the Power of Partnership
Across the nation, state-based health insurance exchanges are searching for ways to better serve their communities while making enrollment easier, more personal, and more accessible for everyone.
How Does Geopolitics Affect the Life Sciences Industry? 3 Executives Weigh In
Executives from Merck, GE Healthcare and Alnylam Pharmaceuticals discuss past hurdles and how it has scrambled supply chains and clinical trial program. One warned about the effects of isolating China.
What does Epic’s Chief Medical Officer Think About ChatGPT Health?
Dr. Jackie Gerhart firmly believes that an AI tool meant to help make sense of a person's health or medical records must be housed within the EHR. She also contends that Epic's digital concierge tool, Emmie, will do much more than simply reactively answer questions posed by the user.
ChatGPT Health: Is it a Missed Opportunity for Microsoft?
In the fall of 2023, Microsoft demoed an AI tool at an industry conference designed to provide insights into a person's medical record integrated within the EHR. But that's the last I heard of it. Now OpenAI is seeking to fulfill the demand for personalized health information with ChatGPT Health.
How Precision Medicine and AI are Evolving: An MD Anderson Perspective
Dr. Prajnan Das, department chair of Gastrointestinal (GI) Radiation Oncology at MD Anderson Cancer Center, talks about how precision medicine has evolved and how AI may actually be the technology that supercharges the conversion of the knowledge about human biology to personalized treatments that work.
For Merck, AI Puts Humans In the “Right Room”
The healthcare industry is contending with a difficult question: how to properly wield AI without taking on too much risk? Inherent in this battle is the role of humans. Here's how Merck's chief data officer is viewing AI.